Advertisement 3SBio names new CFO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

3SBio names new CFO

China-based fully integrated biotechnology company has appointed Bo Tan as its new CFO.

Since joining 3SBio in October 2008, Mr Tan has been acting as the financial advisor for the company, providing advice on the company’s capital market initiatives and overseeing the company’s treasury functions.

Previously, Mr Tan has served as the executive director and a member of investment committee for Bohai Industrial Fund Management Company, a private equity fund in China.

Mr Tan received his MBA degree from Thunderbird School of International Management, an MA degree in economics from the University of Connecticut and a BA degree in economics from Renmin University of China.

Jing Lou, CEO of 3SBio, said: “I am delighted to name Bo as our CFO, given both his recent contributions to 3SBio as financial advisor and the broad wealth of experience he brings, as reflected by his previous roles in the financial services industry and pharmaceutical industry. I strongly believe that his skills and experience will further benefit our company during an important time of our development.”